propofol in spinal anasthesia

Evaluation of effectiveness of using Sub hypnotic dose of propofol to prevent hypotension after spinal anesthesia in caesarean section : Randomized Control Study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

PACTR

Registry ID

PACTR202501608963801

Enrollment

Registered

2025-01-15

Start date

2024-12-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth Anaesthesia

Interventions

spinal anesthesia alone with placebo

spinal anesthesia with subsynaptic dose of propofol

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: ASA II 20-40 years old BMI 30-40 160-180cm, undergoing elective caesarean section under spinal

Exclusion criteria

Exclusion criteria: ASA III,IV,E less than 20 or more than 40 years BMI more than 40 mood disorders or depression known allergy to propofol or local anesthesia drugs using anticoagulant patients refuse

Design outcomes

Primary

Measure	Time frame
to assess the incidence of occurrence of hypotension 5 minute after spinal anesthesia	—

Secondary

Measure	Time frame
to evaluate the effectiveness of Sub hypnotic dose of propofol in reducing the dose of phenylephrine as a vasopressor drug to restore blood pressure with minimal side effect and increase patients satisfaction for spinal anesthesia in caesarean section	—

Countries

Egypt

Contacts

Public Contactlobna saleh

associated professor pharmacology Ain shams university

lobnasaleh_80@yahoo.ca+201005246397

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026